Pfizer, Anthropic, and the most eminent keepers of longevity do deem AI-artificial intelligence-as the chief input shaping health care, from the design of molecules to the trials of medicines and the venerable research into aging.
Biopharma, frontier model laboratories, and the learned halls of academic medicine each report progress most meaningful, yet the wise warn that regulation, compute, and the stubborn tapestry of biology still set the tempo.
Pfizer started 2026 with focus and speed.
Our first quarter results reflect what this team can deliver when we are aligned on what matters: strong commercial performance, meaningful pipeline progress, AI accelerating how we work across the organization and more.
Every day we…
– Albert Bourla (@AlbertBourla) May 5, 2026
Pfizer Reviews an AI-Designed Molecule
Pfizer’s captain, Albert Bourla, declared in a Bloomberg TV discourse that the house is weighing a new molecule wrought by AI.
$PFE – PFIZER CEO SAYS COMPANY IS REVIEWING A NEW MOLECULE IT DESIGNED USING AI
– TENET RESEARCH (@tenet_research) May 5, 2026
The remark sits squarely within Pfizer’s declared stratagem. The house has paid up to $350 million to PostEra since 2020 for AI-designed small molecules and antibody-drug conjugate payloads.
In January, they proclaimed a grand alliance with the Boltz biomolecular foundation model troupe to refine open-source models upon Pfizer’s inner scrolls.
Pfizer Ventures hath previously backed VitaDAO, a venturesome longevity vehicle, thereby feeding its appetite for AI-adjacent biology wagers.
“Once we know the target we must strike, we need a medicine to do that. And AI can design medicines and molecules that fit that target much faster and better than our own devices,” Bourla declared in a Yahoo Finance interview last November.
Anthropic Claims a Frontier Lead
Speaking at Anthropic’s invite-only financial services salon in New York, CEO Dario Amodei swore that Chinese AI ateliers lag frontier US capabilities by six to twelve months, while other US labs trail by one to three months.
Anthropic CEO at NY finance event:
Individual SaaS companies may go bust from AI disruption, even if the software industry overall keeps growing
Mythos has likely found “10s of 1000s of vulnerabilities” that were not publicly known
Chinese AI models are “likely 6 to 12 months…
– Wall St Engine (@wallstengine) May 5, 2026
The affair coincided with the release of Claude Opus 4.7 and a wave of fresh agents pitched at banks, including a financial-crime tool built with FIS.
Amodei also warned of a closing patching window. Mythos hath surfaced tens of thousands of previously unknown software vulnerabilities.
Based on this, he warns that governments and large enterprises have six to twelve months to patch before Chinese models close the gap.
The company’s pre-IPO valuation crossed the threshold of $1 trillion in April, and Amodei told the audience that first-quarter revenue grew about 80 times on an annualized basis.
Longevity Researchers See an Inflection Point
Biomedical gerontologist Aubrey de Grey and immunology professor Derya Unutmaz argued in a BeInCrypto podcast that AI is now the credible road to reversing aging.
Unutmaz predicted most diseases could be addressed within 10 to 15 years, while de Grey pencilled the odds of reaching longevity escape velocity by the late 2030s at roughly fifty percent.
Subscribe to our YouTube channel to watch leaders and journalists provide expert insights
Unutmaz pressed a sharper line on physician practice in the same colloquy.
“Very soon it’s going to be malpractice not to use AI in medicine,” Derya Unutmaz told BeInCrypto.
The week’s triple signs push in one direction: drugmakers, frontier laboratories, and academies converge on AI as healthcare’s chief accelerator, while regulators, compute supply, and data gaps remain their constraints.
Whether Bourla’s molecule joins the trials, whether Amodei’s lab-gap claim survives independent benchmarking, and whether the longevity field yields de Grey’s mouse breakthrough will chart how swiftly the drama moves through the decade.
Read More
- Gold Rate Forecast
- What is Omoggle? The AI face-rating platform taking over Twitch
- Man pulls car with his manhood while on fire to raise awareness for prostate cancer
- Bithumb’s Dance with Fate: Court Halts Ban, But BTC Blunder Looms
- Elden Ring Is Back With A New Free Game, Thanks To The Fans
- Wartales Curse of Rigel DLC Guide – Best Tips, POIs & More
- Beyond Traditional Risk Metrics: Forecasting Market Volatility with Bayesian Networks
- Audible opens first ‘bookless bookstore’ in New York
- How To Grow Money Trees In Animal Crossing: New Horizons
- Apple TV’s Imperfect Women Becomes No. 1 Most-Watched Show Globally
2026-05-07 04:21